Boston Research & Management Inc. lifted its holdings in shares of Procter & Gamble Co (NYSE:PG) by 8.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,252 shares of the company’s stock after purchasing an additional 3,200 shares during the period. Boston Research & Management Inc.’s holdings in Procter & Gamble were worth $3,220,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. HC Financial Advisors Inc. purchased a new stake in Procter & Gamble in the 4th quarter worth approximately $1,738,000. Banco de Sabadell S.A purchased a new stake in Procter & Gamble in the 4th quarter worth approximately $2,179,000. OLD Mutual Customised Solutions Proprietary Ltd. grew its stake in Procter & Gamble by 47.9% in the 4th quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 147,584 shares of the company’s stock worth $13,560,000 after acquiring an additional 47,800 shares during the period. Woodard & Co. Asset Management Group Inc. ADV purchased a new stake in Procter & Gamble in the 4th quarter worth approximately $791,000. Finally, Sawtooth Solutions LLC grew its stake in Procter & Gamble by 57.9% in the 4th quarter. Sawtooth Solutions LLC now owns 17,491 shares of the company’s stock worth $1,607,000 after acquiring an additional 6,415 shares during the period. Institutional investors own 58.36% of the company’s stock.
Shares of NYSE PG opened at $79.06 on Friday. Procter & Gamble Co has a 52-week low of $70.73 and a 52-week high of $93.51. The firm has a market cap of $209.82 billion, a PE ratio of 18.73, a P/E/G ratio of 2.68 and a beta of 0.59. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.83 and a quick ratio of 0.66.
Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 31st. The company reported $0.94 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.04. Procter & Gamble had a net margin of 14.59% and a return on equity of 20.94%. The company had revenue of $16.50 billion during the quarter, compared to analysts’ expectations of $16.52 billion. During the same period in the previous year, the company earned $0.85 EPS. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. As a group, sell-side analysts expect that Procter & Gamble Co will post 4.42 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 15th. Stockholders of record on Friday, October 19th will be paid a dividend of $0.7172 per share. The ex-dividend date is Thursday, October 18th. This represents a $2.87 annualized dividend and a dividend yield of 3.63%. Procter & Gamble’s dividend payout ratio is presently 68.01%.
In related news, insider Kathleen B. Fish sold 599 shares of the company’s stock in a transaction on Monday, August 27th. The shares were sold at an average price of $83.48, for a total transaction of $50,004.52. Following the completion of the sale, the insider now directly owns 38,655 shares of the company’s stock, valued at approximately $3,226,919.40. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Carolyn M. Tastad sold 4,181 shares of the company’s stock in a transaction on Wednesday, August 22nd. The stock was sold at an average price of $83.52, for a total transaction of $349,197.12. The disclosure for this sale can be found here. Insiders have sold a total of 147,186 shares of company stock valued at $12,080,849 over the last three months. Corporate insiders own 1.84% of the company’s stock.
PG has been the subject of several recent analyst reports. Zacks Investment Research cut shares of Procter & Gamble from a “hold” rating to a “sell” rating in a research note on Monday, June 25th. Jefferies Financial Group cut shares of Procter & Gamble from a “buy” rating to a “hold” rating and set a $95.00 target price for the company. in a research note on Monday, July 9th. UBS Group cut shares of Procter & Gamble from a “buy” rating to a “neutral” rating and set a $83.00 target price for the company. in a research note on Wednesday, July 18th. Citigroup lowered their target price on shares of Procter & Gamble from $98.00 to $89.00 and set a “buy” rating for the company in a research note on Friday, July 20th. Finally, Wells Fargo & Co reaffirmed a “hold” rating on shares of Procter & Gamble in a research note on Tuesday, July 31st. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company’s stock. Procter & Gamble currently has an average rating of “Hold” and an average target price of $84.53.
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.
Recommended Story: Outstanding Shares, Buying and Selling Stocks
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.